Until recently the clinical diagnosis of chronic lymphocytic leukaemia (CLL) was based on Rai's staging system (Rai et al., 1975) which accepted as minimum necessary criteria a sustained increase of peripheral blood small lymphocytes above 15 x 109 1 -1 and a lymphocytic infiltration of the bone marrow with more than 30% small mature lymphocytes. However during the last decade the phenotypic analysis of lymphocyte membrane surface markers has been introduced for the classification of lymphoproliferative disorders. The demonstration of a clonal expansion of B or T lymphocytes may be taken as an indication of a neoplastic process even in cases with low lymphocytosis in the peripheral blood and may contribute greatly to the correct diagnosis of cases which otherwise present difficulties in classification.
The typical phenotypic pattern for B-CLL which represents 95% of all cases of CLL is characterised by weak expression of surface immunoglobulin (slg) which is monoclonal with respect to light chain and strong expression of the receptor for mouse rosette formation (Galton & MacLennan, 1982 Rai et al. (1975) .
Methods
Peripheral blood lymphocytes were isolated from fresh heparinised blood after gradient centrifugation in a sodium-metrizoat-ficoll solution (Lymphoprep, Nyegaard, Oslo, Norway). The washed mono-nuclear cells were analysed for surface markers as follows:
B cells were identified by surface immunoglobulin staining using direct immunofluorescence after incubation with FITC-conjugated goat anti-human IgG F(ab')2 and goat antihuman K or A F(ab')2 light chains (Kallestad, Chaska, MN).
Erythrocyte mouse rosette formation (EMR) was studied after incubation of the mononuclear cells with freshly prepared untreated mouse erythrocytes (Catovsky et al., 1976) . Normal control values were 7.4 + 5.8% of mononuclear cells.
T cells (ER) were estimated after rosetting with 2-aminoethyl isothiouronium bromide (AET) treated sheep red blood cells (Kaplan & Clark, 1974) .
T lymphocyte subpopulations were determined in the separated mononuclear cells using indirect immunofluorescence after incubation with monoclonal mouse antibodies (Reinherz & Schlossman, 1980) of the OKT series OKT3, OKT4, OKT8 (Ortho, Raritan, New Jersey) and further staining with FITC-conjugated goat antimouse IgG (Meloy Lab., Springfield).
Serum immunoglobulin levels were determined by radial immunodiffusion with commercial immunodiffusion plates (Meloy Lab., Springfield).
Results
The lymphocyte count in the peripheral blood of the patients ranged from 2.6 x 109 P1 to 14.2x 1091-1 (mean 8.15x 1091 -1) and the percentage of lymphocytes from 50% to 95% (mean 70%). The analysis of the B and T cell markers revealed that of the 36 patients 31 had B-cell and four had a T-cell monoclonal proliferation in the peripheral blood.
B-cell lymphoproliferative syndrome According to clinical histological and laboratory findings cases with B-cell lymphoproliferative syndrome could be classified as follows. Twelve had stage 0 B-CLL, 5 had stage I and one stage II B-CLL and 6 had probably a pure splenomegalic form (PSF) of B-CLL without any lymph node involvement (Tables I to III) .
The mean lymphocyte count and the mean percentage of EMR and ER did not differ in these three groups (Table IV) . Of the 12 stage 0 patients 3 had undetectable slg and 5 very weak expression of slg. Two had low values of EMR formation (4% and 9%) and 2 had borderline values (21% and 24% respectively). The monoclonal sIg was of the K (kappa) type in all cases. Of the 5 patients with stage I CLL one had undetectable slg and 4 type K slg. The percentage of EMR formation was increased in all but one who had a borderline value (24%).
Of the 6 patients with the splenomegalic form of CLL 5 had a type K and one a type A (lambda) sIg. The percentage of EMR formation was increased in 4 but in 2 that had a strong expression of slg it was low (4% and 8% respectively). One of these cases had 25% prolymphocytes in the peripheral blood.
In 8 patients on clinical and histological grounds the diagnosis of non Hodgkin's lymphoma (NHL) was made. Three had in the lymph nodes the picture of immunocytic lymphoma (IcL) with lymphoplasmacytoid cells but in two of them the phenotype of the peripheral blood lymphocytes was that of B-CLL with increased percentage of EMR. The other 5 had the histological picture of lymphocytic lymphoma (LcL). One of these patients had no detectable monoclonal B cell poulations in the peripheral blood. Four out of the 5 patients had a normal percentage of EMR (Table III) .
The geometric mean values of serum immunoglobulin concentration in the different groups studied is shown in Table IV T-cell lymphoproliferative syndrome Four patients had increased T-cells which reacted in a high percentage with OKT8 monoclonal antibody ( Table V) . None of these patients had lymph node enlargement but two had splenomegaly. Case 4 had undergone splenectomy for haemolytic anaemia when tested. The bone marrow was infiltrated with relatively small numbers of lymphocytes in all these cases. The level of serum immunoglobulins was moderately affected in these patients.
Discussion
The study of cell surface markers in lymphoproliferative disorders with low absolute lymphocytosis is interesting for two main reasons: (a) It may be helpful for the diagnosis, classification and staging of early forms of CLL. (b) It may contribute to the differential diagnosis of two closely related lymphoproliferative diseases which differ only in the major involvement of the blood -CLL and lymphocytic lymphoma. Initially, according to the Rai staging system, patients with persistent lymphocytosis below 15 x 1091-1 who had bone marrow infiltration <30% were excluded from the definition of CLL because many of these patients had lymph node enlargement and were classified as having lymphocytic lymphoma. Rai and his colleagues now accept a lymphocytic count of 5 x 109 1 -1 as the lower limit for the diagnosis of CLL (Galton, 1981 Cherchi & Catovsky (1980) report that 4 patients (1.6%) had <30% EMR. In our study the number of EMR forming cells in healthy control subjects ranged from 2% to 16%. On the basis of these studies it may be suggested that in early forms of B-CLL marginal increases of EMR forming cells between 20-25% may indicate the presence of a neoplastic lymphocyte population.
Among the cases with normal or strong expression of slg 6 patients had splenomegaly without lymph node enlargement and two of these patients were negative for EMR but only one had the clinical features of prolymphocytic leukaemia, although he was atypical in having low lymphocyte count. The other patients, in addition to increased numbers of B cells, had increased percentage of EMR (28-54%). These findings indicate that the majority of cases defined on clinical evidence as PSF of B-CLL (Galton & MacLennan, 1982) have the classical phenotype of B-CLL.
A slightly increased percentage of EMR has been found only in one of the 5 cases diagnosed as having lymphocytic lymphoma. Increased EMR formation has only rarely been associated with immunocytic lymphoma and non Hodgkin's lymphoma (Gupta et al., 1976a; Stein & Toskdorf, 1979) .
However it is interesting that two of the three cases with the histological picture of immunocytic lymphoma in the lymph nodes had increased numbers of EMR in the peripheral blood. This observation confirms the reported findings that in CLL cells of the malignant clone may be arrested at different maturation stages having different homing properties (Cherchi & Catovsky, 1980; R6bert et al., 1983) . Gordon et al. (1983) investigated neoplastic populations from cases of B-CLL and found a variety of patterns of maturation stages ranging from 'pre-B' to 'secretory-B' forms. Classification of the cases into 'true' B-CLL and immunocytoma revealed no strict association of the histopathologic entities with any particular phenotypic group, since the presence of lymphoplasmacytoid and/or plasma cell features in the lymph nodes or bone marrow of the patients did not necessarily relate to the predominant phenotype of the leukaemic cells in the circulation. These observations and our own findings indicate that only the long follow up of the patients with moderate lymphocytosis may demonstrate whether this group of B-lymphoproliferative disorders will be heterogenous in their evolution towards CLL of advanced stages, lymphocytic lymphoma or immunocytoma. It is interesting that in these cases of B-lymphoproliferative syndrome with lymphocyte counts < 15 x 109 1-1 the levels of serum immunoglobulins and especially those of IgA and IgM are much less affected than in cases with high lymphocytosis (Galton & MacLennan, 1982; Economidou et al., 1984) .
Among the 36 patients that were investigated, 4 (11.1%) had the features of T8 lymphocytosis (Brisbane et al., 1983) . Since this disorder usually presents with low leucocyte counts or neutropenia it was to be expected that it would be found more frequently than anticipated among our cases which were selected on the basis of low lymphocyte counts (<15x 1091-1).
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